G14 7.5 (Meloxicam 7.5 mg)

Pill imprint G14 7.5 has been identified as Meloxicam 7.5 mg.

Meloxicam is used in the treatment of inflammatory conditions; osteoarthritis; fibromyalgia; tendonitis; rheumatoid arthritis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Meloxicam

Imprint:

G14 7.5

Strength:

7.5 mg

Color:

Yellow

Size:

8.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Nonsteroidal anti-inflammatory agents

Pregnancy Category:

C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation

CSA Schedule:

Not a controlled drug

Manufacturer:

Glenmark Generics Inc.

National Drug Code (NDC):

68462-0140

Inactive Ingredients:

silicon dioxide
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
trisodium citrate dihydrate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.